Meridian Bioscience, Inc. - stock earnings
Stock symbol VIVO is outdated, potentially delisted? Maybe it is available on other exchange?
VIVO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q3 | 5.7 million USD | 65.7 million USD |
| 2022Q2 | -7.3 million USD | 67.8 million USD |
| 2022Q1 | 28.8 million USD | 111.2 million USD |
| 2021Q4 | 15.3 million USD | 88.3 million USD |
| 2021Q3 | 6.7 million USD | 76.2 million USD |
| 2021Q2 | 11.7 million USD | 63.5 million USD |
| 2021Q1 | 26.3 million USD | 85.3 million USD |
| 2020Q4 | 26.8 million USD | 92.9 million USD |
| 2020Q3 | 6.5 million USD | 64.2 million USD |
VIVO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | 42.5 million USD | 333.0 million USD |
| 2021 | 71.4 million USD | 317.9 million USD |
| 2020 | 46.2 million USD | 253.7 million USD |
| 2019 | 24.4 million USD | 201.0 million USD |
| 2018 | 23.8 million USD | 213.6 million USD |
| 2017 | 21.6 million USD | 200.8 million USD |
VIVO
Price: $33.97
52 week price:
Dividend Yield: 1.04%
Forward Dividend Yield: 2.61%
Payout Ratio Range:
Earnings Per Share: 0.86 USD
P/E Ratio: 35.39
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 6.4 million
Ebitda: 10.1 millionMarket Capitalization: 1.5 billion
Average Dividend Frequency: 2